Canada's FSD Pharma to buy Israeli medical cannabis firm Therapix

Canada's FSD Pharma Inc signed a letter of intent to acquire Israel's Therapix Biosciences Ltd for $48 million in stock, combining two complementary businesses focused on the research and development of cannabinoid treatments.

from Reuters: Health https://ift.tt/2D0ODDZ
via IFTTT

• Tweet
• Share
• Share
• Share
• Share